Response to: 'Biologic discontinuation studies: a systematic review of methods' by van der Maas et al
| Autor: | Michael E. Weinblatt, Daniel H. Solomon, Sang Cheol Bae, Mitsumasa Kishimoto, Arthur Kavanaugh, Kazuo Matsui, Yoon-Kyoung Sung, Shigeto Tohma, Kazuki Yoshida |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Adult-onset Still's disease
medicine.medical_specialty Biological Products business.industry Amyloidosis Immunology Disease medicine.disease Connective tissue disease Dermatology General Biochemistry Genetics and Molecular Biology Discontinuation Arthritis Rheumatoid Rheumatology Withholding Treatment Rheumatoid arthritis Antirheumatic Agents medicine Immunology and Allergy Humans Antirheumatic drugs business |
| Zdroj: | Annals of the rheumatic diseases. 73(1) |
| ISSN: | 1468-2060 |
| Popis: | We would like to thank van der Maas and colleagues1 for their interest in, and useful feedback on, our review.2 They raise several important points. First, regarding the interpretation of the studies included in the review, we focused on studies examining discontinuation of biologic disease modifying antirheumatic drugs (DMARDs) that examined patient outcomes. Thus, we had difficulty in … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|